Dudediligence.

Sera Prognostics, Inc

SERANASDAQ · Services-Medical Laboratories
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$29,000Sep ’24$24,000Dec ’24$38,000Mar ’25$17,000Jun ’25$16,000Sep ’25$10,000Dec ’25$14,000Mar ’26$30,000Jun ’26
Net income, by quarter
−$7.9MSep ’24−$8.6MDec ’24−$8.2MMar ’25−$8.0MJun ’25−$7.8MSep ’25−$7.9MDec ’25−$8.4MMar ’26−$9.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$82,000$268,000$306,000$77,000$81,000
Gross profitnone on filenone on file$96,000−$5,000−$83,000
Operating income−$35.4M−$45.7M−$39.8M−$36.6M−$36.5M
Net income−$35.0M−$44.2M−$36.2M−$32.9M−$31.9M
Operating cash flow−$31.6M−$34.6M−$27.2M−$14.2M−$25.6M
Free cash flow−$32.9M−$35.4M−$27.3M−$14.2M−$26.3M
Cash$58.9M$29.9M$3.9M$4.0M$3.9M
Shares outstanding15.0M30.9M31.2M33.2M47.7M